Acurex Biosciences
PrivateLast Round
Grant
May 27, 2026
Total Funding Raised
$2.52M
Momentum
Top 25%
of companies Caplight tracks
Company Overview
Acurex Biosciences is a biotechnology company that develops small-molecule medicines for the treatment of neurodegenerative diseases and movement disorders.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Precision Medicine
Business Model
B2B
Customer Profile
Government Contracts, Services & Consulting
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Acurex Biosciences Comparables
Compare Acurex Biosciences with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Arviat Pharmaceuticals, Inc. | 86% | |
| Praxis Precision Medicines, Inc. | 81% | |
| Vincere Biosciences | 80% |
Acurex Biosciences Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Grant | May 27, 2026 | ||||
| Series A | May 27, 2026 | ||||
| Grant | Aug 7, 2024 | ||||
| Grant | Apr 27, 2022 | ||||
| Grant | Sep 30, 2021 | ||||
Grant | Aug 31, 2021 |
Acurex Biosciences Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Aligning Science Across Parkinson's (ASAP) | Grant |
| NIH RADx | Grant |
| The Michael J. Fox Foundation for Parkinson's Research | Grant, Seed |
| The Silverstein Foundation for Parkinson's with GBA | Grant, Seed |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jul 25, 2026
Monthly visitors increased by 48% MoM.
- May 27, 2026
Completed a Series A funding round.
Acurex Biosciences Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request accessFrequently Asked Questions
Common questions about Acurex Biosciences's valuation, stock price, and market status.
Is Acurex Biosciences a public or private company?
Acurex Biosciences is a private company.
What is the current stock price of Acurex Biosciences?
Acurex Biosciences is a private company with no public stock price. No recent secondary market data is available.
How much is Acurex Biosciences worth (valuation)?
Valuation information for Acurex Biosciences is not publicly available.
Can I buy Acurex Biosciences stock?
Acurex Biosciences shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.
When was Acurex Biosciences's last funding round?
Acurex Biosciences's most recent funding round was Grant on May 27, 2026.
Who are the main investors in Acurex Biosciences?
Key investors in Acurex Biosciences include Aligning Science Across Parkinson's (ASAP), NIH RADx, The Michael J. Fox Foundation for Parkinson's Research, The Silverstein Foundation for Parkinson's with GBA.
Will Acurex Biosciences IPO soon?
No public IPO plans have been announced for Acurex Biosciences.
How can I track Acurex Biosciences secondary market activity?
Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor Acurex Biosciences's secondary market activity and sign up for updates.